These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2085148)

  • 41. A specific enzyme-linked immunosorbent assay for definition of the IgG antibody response to disulphide-conjugated D-penicillamine in the rabbit.
    Foster AL; Park BK; Coleman JW
    Int Arch Allergy Appl Immunol; 1987; 84(3):271-6. PubMed ID: 3308711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pharmacokinetics of D-penicillamine in man.
    Wiesner RH; Dickson ER; Carlson GL; McPhaul LW; Go VL
    J Rheumatol Suppl; 1981; 7():51-5. PubMed ID: 6939886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The metabolism of 35S-D-penicillamine in man.
    Waring RH; Mitchell SC
    Xenobiotica; 1988 Feb; 18(2):235-44. PubMed ID: 3376495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacokinetic studies after oral application of radioactively labelled D-penicillamine].
    Patzschke K; Wegner L; Kaller H; Horster FA
    Z Rheumatol; 1977; 36(3-4):96-105. PubMed ID: 871071
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose, plasma concentration and response relationships of D-penicillamine in patients with rheumatoid arthritis.
    Brooks PM; Miners JO; Smith K; Smith MD; Fearnley I; Birkett DJ
    J Rheumatol; 1984 Dec; 11(6):772-5. PubMed ID: 6520830
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Covalent disulfide binding of human IL-1 beta to alpha 2-macroglobulin: inhibition by D-penicillamine.
    Teodorescu M; McAfee M; Skosey JL; Wallman J; Shaw A; Hanly WC
    Mol Immunol; 1991; 28(4-5):323-31. PubMed ID: 1712069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. D-penicillamine, a non-bilirubin-displacing drug in neonatal jaundice.
    Brodersen R; Lakatos L; Karmazsin L
    Acta Paediatr Scand; 1980 Jan; 69(1):31-5. PubMed ID: 6892748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. D-penicillamine-induced autoantibodies in a mouse model.
    Brik R; Tenenbaum G; Blank M; Shoenfeld Y; Barzilai D; Bloch K; Vardi P
    Clin Exp Rheumatol; 1995; 13(4):483-8. PubMed ID: 7586781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intracerebroventricular administration of the (1→6)-β-d-glucan (lasiodiplodan) in male rats prevents d-penicillamine-induced behavioral alterations and lipoperoxidation in the cortex.
    Malfatti CR; Dos Santos FS; Wouk J; da Silva LA; Michel RG; Snak AL; Czervinski T; da Cunha MA; Barbosa AM; Dekker RF
    Pharm Biol; 2017 Dec; 55(1):1289-1294. PubMed ID: 28274189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of D-penicillamine in patients with rheumatoid arthritis undergoing hemodialysis.
    Matthey F; Perrett D; Greenwood RN; Baker LR
    Clin Nephrol; 1986 May; 25(5):268-71. PubMed ID: 3720037
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kinetic analysis of covalent binding between N-acetyl-L-cysteine and albumin through the formation of mixed disulfides in human and rat serum in vitro.
    Harada D; Naito S; Otagiri M
    Pharm Res; 2002 Nov; 19(11):1648-54. PubMed ID: 12458670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Difference circular dichroism studies of copper and nickel binding to D-penicillamine in the presence of human serum albumin.
    Mohanakrishnan P; Chignell CF
    Biochem Pharmacol; 1985 Mar; 34(5):675-7. PubMed ID: 3977943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination and metabolism of dithiol chelating agents. XVII. In humans, sodium 2,3-dimercapto-1-propanesulfonate is bound to plasma albumin via mixed disulfide formation and is found in the urine as cyclic polymeric disulfides.
    Maiorino RM; Xu ZF; Aposhian HV
    J Pharmacol Exp Ther; 1996 Apr; 277(1):375-84. PubMed ID: 8613944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro monocyte-lymphocyte interaction influenced by d-penicillamine.
    De Vries E; Haasnoot CJ; Van der Weij JP; Cats A
    Clin Exp Immunol; 1982 Feb; 47(2):474-80. PubMed ID: 7075029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A western blot approach to detection of human plasma protein conjugates derived from D-penicillamine.
    Laycock CA; Phelan MJ; Bucknall RC; Coleman JW
    Ann Rheum Dis; 1994 Apr; 53(4):256-60. PubMed ID: 8203955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of D-penicillamine on pentylenetetrazole-induced seizures in mice: involvement of nitric oxide/NMDA pathways.
    Rahimi N; Sadeghzadeh M; Javadi-Paydar M; Heidary MR; Jazaeri F; Dehpour AR
    Epilepsy Behav; 2014 Oct; 39():42-7. PubMed ID: 25173990
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cells.
    Gupte A; Mumper RJ
    Free Radic Biol Med; 2007 Nov; 43(9):1271-8. PubMed ID: 17893040
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polypeptide conjugates of D-penicillamine and idarubicin for anticancer therapy.
    Wadhwa S; Mumper RJ
    J Control Release; 2012 Mar; 158(2):215-23. PubMed ID: 22063001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Determination of D-penicillamine and its metabolites in blood and urine].
    Kyogoku K; Inoue K; Otake T; Noda K; Ohzeki M
    Yakugaku Zasshi; 1982 Apr; 102(4):322-7. PubMed ID: 7131247
    [No Abstract]   [Full Text] [Related]  

  • 60. [Studies on the formation of mixed disulfides between D-penicillamine and serum proteins (author's transl)].
    Planas-Bohne F
    Res Exp Med (Berl); 1973 Nov; 161(4):289-97. PubMed ID: 4768650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.